Search Results for: CLINICAL TRIALS Accelerating the Clinical
Articles
Henlius & Sermonix Announce Strategic Collaboration & Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene January 11, 2024
Sermonix Pharmaceuticals Inc. and Shanghai Henlius Biotech, Inc. recently announced a strategic collaboration agreement in which Henlius will receive exclusive...Ardena's New Aseptic Fill-Finish Plant in Ghent Receives GMP License November 29, 2023
Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has been granted a Good Manufacturing Practice (GMP) license by the….
Roivant & Priovant Announce Results From Phase 2 Study of Oral Brepocitinib in Systemic Lupus Erythematosus November 27, 2023
Roivant and Priovant recently announced the Phase 2 study evaluating oral brepocitinib in adult patients with moderate to severe active...Symbiosis Pharmaceutical Services Granted MHRA License Following Significant Investment November 21, 2023
Symbiosis Pharmaceutical Services has recently launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and...eXmoor Completes Expansion Into Full-Service Cell & Gene Therapy CDMO Partner With Opening of GMP Facilities October 11, 2023
eXmoor pharma recently launched its new Cell and Gene Therapy Centre GMP facility, to support the simultaneous production of multiple...Certara Simcyp Group Awarded Two New Grants From US FDA August 29, 2023
Programs focus on use of physiologically-based pharmacokinetic (PBPK) modeling for demonstrating virtual bioequivalence and predicting drug absorption of topical formulations…..
2023 Analytical Testing eBook – Analytical Testing Evolves With the Pharma Industry August 14, 2023
In this fourth annual Analytical Testing e-book, learn more about Alcami, Stevanati Group, and West and their current contributions and offerings in the outsourcing analytical testing market, as it continues to be a time and money saver for bio/pharma companies.
PLATFORM DEVICE - Alina: Shining the “Light” on the Benefits of a Platform Approach to Treating Chronic Conditions June 5, 2023
Adam Stops, PhD, says the key to the success of any drug delivery device are factors such as proven technology, low development costs, fast time-to-market, and a strong intellectual property (IP) position for the pharma company, and against this background, platform drug delivery devices have become more important than ever.
SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Putting Customers First June 5, 2023
Contributor Cindy H. Dubin speaks with several leading CDMOs from around the globe on their unique development and manufacturing capabilities and technologies, and presents real-world examples of how they have put these to use to produce innovative compounds, lower development costs, and shorten time to market.
SPECIAL FEATURE - Parenteral Drug Delivery: Could a Dose of AI Improve Development? May 1, 2023
Contributor Cindy H. Dubin speaks with several innovative companies to highlight the strides they are currently making toward improving dose accuracy, integrating design safety, and accelerating time to market.
Ovid Therapeutics Announces Collaboration With Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors May 1, 2023
Ovid Therapeutics Inc. and Graviton Bioscience Corporation recently announced a collaboration agreement to innovate novel medicines they believe will significantly change….
Certara Announces Release of Simcyp PBPK Simulator Version 22, Expanding Ability to Simulate Untested Scenarios for New Patient & Therapeutic Types March 7, 2023
Certara, Inc. recently announced the release of Simcyp Simulator Version 22, which includes new capabilities and updated features to the...NeOnc Technologies Engages Anova Enterprises to Pursue Pediatric Brain Tumor Indication & FDA Fast-Track Status March 6, 2023
NeOnc Technologies Holdings, Inc. has recently expanded its engagement of Anova Enterprises to pursue a pediatric indication for NEO100, an...AUTOMATED SOLUTIONS - Automation & Shared Knowledge Pave the Way Into the Future March 1, 2023
Luca Valeggia says by no means is automation a novel concept for most research labs, but its swift advancement and expansion into new fields such as synthetic biology have shown us that we are only witnessing the start of what is possible.
EyePoint & Rallybio Announce Research Collaboration February 27, 2023
Rallybio Corporation and EyePoint Pharmaceuticals, Inc recently announced a research collaboration. The partnership will evaluate sustained delivery of Rallybio’s inhibitor of complement component….
PATIENTS-ON-A-CHIP - Why Artificial Intelligence Will Be the Tipping Point to Remove the Faulty Reliance on Animal Testing in Drug Discovery January 16, 2023
Isaac Bentwich, MD, believes Advanced Bio-AI platforms that integrate artificial intelligence and machine learning with patients-on-a-chip, real-time nano-sensing, and stem cell genomic diversity technologies are the future of drug discovery and development.
Centogene & Denali Therapeutics Extend World’s Largest Observational Study on Parkinson’s Disease Genetics January 9, 2023
Centogene N.V. recently announced it has extended the Rostock International Parkinson's Disease (ROPAD) Study to recruit and genetically test additional...Enzyvant Announces Merger With Altavant December 6, 2022
Combined company has full range of capabilities required to advance bold science for rare diseases in immunology and cardiopulmonology….
Syneos Health Expands Partnership With Datavant to Accelerate Delivery of New Therapies to Patients October 11, 2022
Syneos Health recently announced an expanded partnership with Datavant, the leader in helping organizations securely connect health data. The increasing collaboration between the companies will further leverage….
Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma & Fluidda September 22, 2022
Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products, recently announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging…..
WHITEPAPER: Lonza Engine® & Xcelodose®: Accelerating Preclinical & Clinical Trial Pathways With Target Dosing Technologies
Learn how Lonza helps developers quickly assess new drug candidates while minimizing API consumption through efficient excipient screenings, encapsulation and...
